154 related articles for article (PubMed ID: 35086058)
1. Examining subjective experience of aberrant salience in young individuals at ultra-high risk (UHR) of psychosis: A 1-year longitudinal study.
Azzali S; Pelizza L; Scazza I; Paterlini F; Garlassi S; Chiri LR; Poletti M; Pupo S; Raballo A
Schizophr Res; 2022 Mar; 241():52-58. PubMed ID: 35086058
[TBL] [Abstract][Full Text] [Related]
2. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
[TBL] [Abstract][Full Text] [Related]
3. Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study.
Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2020 Dec; 29(12):1645-1657. PubMed ID: 32016572
[TBL] [Abstract][Full Text] [Related]
4. Tracking salience in young people: A psychometric field test of the Aberrant Salience Inventory (ASI).
Raballo A; Cicero DC; Kerns JG; Sanna S; Pintus M; Agartz I; Pintus E; Corrias I; Lai V; Petretto DR; Carta MG; Preti A
Early Interv Psychiatry; 2019 Feb; 13(1):64-72. PubMed ID: 28719056
[TBL] [Abstract][Full Text] [Related]
5. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation on negative symptoms in young people at Ultra-High Risk (UHR) of psychosis: results from a 2-year follow-up study in a real-world care setting.
Pelizza L; Leuci E; Quattrone E; Azzali S; Paulillo G; Pupo S; Pellegrini P; Menchetti M
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1761-1771. PubMed ID: 37029806
[TBL] [Abstract][Full Text] [Related]
8. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
[TBL] [Abstract][Full Text] [Related]
9. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
10. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
[TBL] [Abstract][Full Text] [Related]
11. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
12. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
13. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
[TBL] [Abstract][Full Text] [Related]
14. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
15. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
16. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): Field test and psychometric features.
Pelizza L; Paterlini F; Azzali S; Garlassi S; Scazza I; Pupo S; Simmons M; Nelson B; Raballo A
Early Interv Psychiatry; 2019 Aug; 13(4):810-817. PubMed ID: 29696795
[TBL] [Abstract][Full Text] [Related]
17. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
[TBL] [Abstract][Full Text] [Related]
18. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
[TBL] [Abstract][Full Text] [Related]
20. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
Rekhi G; Rapisarda A; Lee J
Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
